About IJCPCR

PRELIMINARY RESULTS OF A POTENTIAL NEW USE OF CLARITHROMYCIN IN THE MANAGEMENT OF CHRONIC RHINOSINUSITIS
Article Information
Language
Corres.Author
Email
Accepted Date
File size
No of Downloads
Published by
Full Text
After endoscopic sinus surgery, patients with chronic rhinosinusitis with polyps (CRSwP) should get long-term treatment with low-dose clarithromycin to test its effectiveness and safety (ESS). We found 10 people who had CRSwP and had them undergo bilateral electroshock therapy (ESS). After surgery, patients were given nasal saline solution and steroid sprays to cleanse out their nasal passages (beclomethasone). During follow-up, when nasal obstruction, odour loss, headache, and the onset of viscous secretions appeared in some patients, their symptoms worsened. As a result, all patients continued treatment with saline nasal irrigation, topical steroid therapy, and macrolide (clarithromycin 500 mg/pill: 1 pill per day for 3 days per week). It was determined that the effectiveness of therapy was determined by conducting a SNOT-22 questionnaire and an endoscopic appearance score (EAS). Sneezing, As well as, hyposmia, thick mucus secretions on the SNOT-22, and reduced secretions and enlargement of the nasal mucosa on the EAS all exhibited statistically significant improvements (p<0.05) in both tests, according to the researchers' findings. This study's early findings suggest an antibacterial and immunomodulatory effect of low-dose clarithromycin for a duration of one month on CRSwP patient complaintsddd